TJX
64
2
USB
55
-6
GE
67
2
XYL
49
4
CF
57
-2
DE
63
3
BF.B
33
2
STI
14
-17
CA
38
6
MA
64
7
DRI
53
5
ADT
53
3
KMB
39
2
ROST
63
12
KHC
24
13
ADBE
49
3
MAS
58
2
CSX
60
3
HAS
33
3
GOOGL
40
-5
TJX
64
2
USB
55
-6
GE
67
2
XYL
49
4
CF
57
-2
DE
63
3
BF.B
33
2
STI
14
-17
CA
38
6
MA
64
7
DRI
53
5
ADT
53
3
KMB
39
2
ROST
63
12
KHC
24
13
ADBE
49
3
MAS
58
2
CSX
60
3
HAS
33
3
GOOGL
40
-5
Financhill
Back

DBV Technologies SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
28

DBVT
DBV Technologies SA

Last Price:
0.47
Seasonality Move:
4.2%
Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
53.66%
Sell
28
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $0.47. The Score for DBVT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $0.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 27.42 Sell
Chaikin Money Flow: -12182 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.56 - 0.8) Sell
Bollinger Bands (100): (0.67 - 0.91) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 1207506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.8 - 1.2) Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.53 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.69 Sell
200-day SMA: 1.08 Sell
8-day EMA: 0.53 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.7 Sell
200-day EMA: 1.11 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.73 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.72 Sell
50-day EMA: 0.83 Sell
200-day EMA: 0.99 Sell

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):